Alcon, a global leader in eye care committed to helping people see brilliantly, has been named one of the ‘Best Employers in Singapore’ for the second consecutive year, following its recognition in 2021. This honor highlights Alcon’s dedication to fostering…
Exact Sciences Corp. (NASDAQ: EXAS), a leader in cancer screening and diagnostics, has announced that it will present modeling data assessing the benefits and burdens of established colorectal cancer (CRC) screening strategies, including the Cologuard Plus™ test, at the American…
Odyssey Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on improving treatments for autoimmune and inflammatory diseases, announced that new translational data for its RIPK2 scaffolding inhibitor, OD-07656, will be presented at the American College of Gastroenterology (ACG) Annual Scientific Meeting…
Medibank is advocating for a significant expansion of hospital care in the home to ease pressure on the traditional hospital system. A new KPMG report commissioned by Medibank outlines potential economic benefits of this approach, estimating that by 2030, up…
Henry Schein Medical, part of Henry Schein, Inc. (Nasdaq: HSIC), is exhibiting at the EMS & FIRE PRO Expo from October 24-26, 2024. Located at booth #718, the exhibit features a range of products and technologies aimed at advancing the…
Elucid has announced that Noridian will begin covering AI-enabled quantitative coronary plaque analysis, including its FDA-cleared PlaqueIQ™ image analysis software, starting December 8, 2024. With this decision, five out of seven Medicare Administrative Contractors (MACs) will offer coverage for this…
Jupiter Endovascular, Inc., a medical technology startup focused on pioneering endovascular procedures with its Endoportal Control™ platform, has announced the successful treatment of the first U.S. patient in the SPIRARE II pivotal study. This study evaluates the Vertex Pulmonary Embolectomy…
Vertex Pharmaceuticals (Nasdaq: VRTX) has shared updates on its pipeline for kidney diseases, including IgA nephropathy (IgAN), primary membranous nephropathy (pMN), and APOL1-mediated kidney disease (AMKD). The updates highlight the potential of Vertex’s investigational therapies, showcasing positive new data on…
Centene Corporation (NYSE: CNC) has announced its financial results for the third quarter ending September 30, 2024. Key highlights include: CEO Sarah M. London noted, “Our diversified portfolio has allowed us to successfully navigate a dynamic landscape this quarter. We…
Siemens Healthineers is revolutionizing clinical lab automation by consolidating 25 tasks typically performed manually by staff, significantly reducing manual workflow steps by 75%. Traditional lab automation relies on a track system to transport samples, but the Atellica Integrated Automation system…
HCA Healthcare, Inc. (NYSE: HCA) has released its financial results for the third quarter ending September 30, 2024. Key Metrics: CEO Sam Hazen praised the team for their response to recent hurricanes, emphasizing their commitment to patient care. Q3 Performance…
The CVS Health® Foundation has announced a $1.5 million funding initiative to enhance access to healthcare services, medically tailored meals, and transportation for chronic disease patients in Atlanta. This funding will support partnerships with Good Samaritan Health Center, Open Hand…